Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis.
Rosti V, Bonetti E, Bergamaschi G, Campanelli R, Guglielmelli P, Maestri M, Magrini U, Massa M, Tinelli C, Viarengo G, Villani L, Primignani M, Vannucchi AM, Frassoni F, Barosi G; AGIMM Investigators. Rosti V, et al. Among authors: frassoni f. PLoS One. 2010 Dec 9;5(12):e15277. doi: 10.1371/journal.pone.0015277. PLoS One. 2010. PMID: 21151606 Free PMC article.
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker.
Piaggio G, Rosti V, Corselli M, Bertolotti F, Bergamaschi G, Pozzi S, Imperiale D, Chiavarina B, Bonetti E, Novara F, Sessarego M, Villani L, Garuti A, Massa M, Ghio R, Campanelli R, Bacigalupo A, Pecci A, Viarengo G, Zuffardi O, Frassoni F, Barosi G. Piaggio G, et al. Among authors: frassoni f. Blood. 2009 Oct 1;114(14):3127-30. doi: 10.1182/blood-2008-12-190991. Epub 2009 Jul 23. Blood. 2009. PMID: 19628707 Free article.
A novel assay to detect calreticulin mutations in myeloproliferative neoplasms.
Rosso V, Petiti J, Bracco E, Pedrola R, Carnuccio F, Signorino E, Carturan S, Calabrese C, Bot-Sartor G, Ronconi M, Serra A, Saglio G, Frassoni F, Cilloni D. Rosso V, et al. Among authors: frassoni f. Oncotarget. 2017 Jan 24;8(4):6399-6405. doi: 10.18632/oncotarget.14113. Oncotarget. 2017. PMID: 28031530 Free PMC article.
Emerging targets for hematological malignancies.
Cilloni D, Frassoni F, Saglio G. Cilloni D, et al. Among authors: frassoni f. Curr Opin Drug Discov Devel. 2010 Sep;13(5):548-58. Curr Opin Drug Discov Devel. 2010. PMID: 20812146 Review.
Genetic Screening for Potential New Targets in Chronic Myeloid Leukemia Based on Drosophila Transgenic for Human BCR-ABL1.
Lo Iacono M, Signorino E, Petiti J, Pradotto M, Calabrese C, Panuzzo C, Caciolli F, Pergolizzi B, De Gobbi M, Rege-Cambrin G, Fava C, Giachino C, Bracco E, Saglio G, Frassoni F, Cilloni D. Lo Iacono M, et al. Among authors: frassoni f. Cancers (Basel). 2021 Jan 14;13(2):293. doi: 10.3390/cancers13020293. Cancers (Basel). 2021. PMID: 33466839 Free PMC article.
Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISH.
Rosso V, Bracco E, Pedrola R, Carturan S, Signorino E, Petiti J, Calabrese C, Nicoli P, De Gobbi M, Gaidano V, Gallo D, Ulisciani S, Fava C, Rege-Cambrin G, Frassoni F, Saglio G, Cilloni D. Rosso V, et al. Among authors: frassoni f. Biomark Res. 2015 Jul 3;3:15. doi: 10.1186/s40364-015-0039-y. eCollection 2015. Biomark Res. 2015. PMID: 26146560 Free PMC article.
The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy.
Gallo D, Nicoli P, Calabrese C, Gaidano V, Petiti J, Rosso V, Signorino E, Carturan S, Bot-Sartor G, Volpe G, Frassoni F, Saglio G, Cilloni D. Gallo D, et al. Among authors: frassoni f. Cancer Med. 2016 Jul;5(7):1650-3. doi: 10.1002/cam4.735. Epub 2016 May 11. Cancer Med. 2016. PMID: 27167495 Free PMC article.
Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection.
Carturan S, Petiti J, Rosso V, Calabrese C, Signorino E, Bot-Sartor G, Nicoli P, Gallo D, Bracco E, Morotti A, Panuzzo C, Gottardi E, Frassoni F, Saglio G, Cilloni D. Carturan S, et al. Among authors: frassoni f. Oncotarget. 2016 Nov 8;7(45):74082-74096. doi: 10.18632/oncotarget.12269. Oncotarget. 2016. PMID: 27765915 Free PMC article.
326 results